Key Metrics
CiteScore 

4.7
H-Index 

79
Impact Factor 

< 5
SJR 

Q1Urology

SNIP 

1.01
Recommended pre-submission checks
Powered by 

Topics Covered on Urologic Oncology: Seminars and Original Investigations
Urologic Oncology: Seminars and Original Investigations Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Urologic Oncology: Seminars and Original Investigations ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Urologic Oncology: Seminars and Original Investigations
Evaluating BCG response in primary and metachronous non-muscle invasive bladder cancer following prior upper tract urothelial cancer: A systematic review and meta-analysis.
- 1 Jun 2026
- Urologic oncology
Outcomes of consolidative surgery following enfortumab vedotin plus pembrolizumab for advanced urothelial cancer: A real-world experience.
- 1 Jun 2026
- Urologic oncology
Adequate Bacillus Calmette-Guérin maintenance therapy improves recurrence-free survival in high-risk non-muscle-invasive bladder cancer: A conditional survival study.
- 1 Jun 2026
- Urologic oncology
Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.
- 1 Jun 2026
- Urologic oncology
Clinical trial participation in kidney, bladder, and prostate malignancies in the United States: Sociodemographic distribution and impact on survival.
- 1 Jun 2026
- Urologic oncology
Casein kinase 1α inhibition reduces prostate cancer cells viability: Role of the autophagy mechanism.
- 1 Jun 2026
- Urologic oncology
Evaluating BCG response in primary and metachronous non-muscle invasive bladder cancer following prior upper tract urothelial cancer: A systematic review and meta-analysis.
- 1 Jun 2026
- Urologic oncology
Outcomes of consolidative surgery following enfortumab vedotin plus pembrolizumab for advanced urothelial cancer: A real-world experience.
- 1 Jun 2026
- Urologic oncology
Adequate Bacillus Calmette-Guérin maintenance therapy improves recurrence-free survival in high-risk non-muscle-invasive bladder cancer: A conditional survival study.
- 1 Jun 2026
- Urologic oncology
Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable disease.
- 1 Jun 2026
- Urologic oncology
Clinical trial participation in kidney, bladder, and prostate malignancies in the United States: Sociodemographic distribution and impact on survival.
- 1 Jun 2026
- Urologic oncology
Casein kinase 1α inhibition reduces prostate cancer cells viability: Role of the autophagy mechanism.
- 1 Jun 2026
- Urologic oncology